Skip to main content
. 2010 Apr 23;101(8):1840–1845. doi: 10.1111/j.1349-7006.2010.01601.x

Table 7.

 The best tumor response during treatment: number (%) of patients in efficacy population

Best tumor response Inotuzumab ozogamicin treatment
1.3 mg/m2 (n = 3) 1.8 mg/m2 (n = 10) Total (n = 13)
CR, CRu 3 (100) 4 (40) 7 (54)
PR 0 4 (40) 4 (31)
OR 3 (100) 8 (80) 11 (85)
SD 0 2 (20) 2 (15)

CR, complete response; CRu, unconfirmed complete response; OR, overall response (CR + CRu + PR); PR, partial response; SD, stable disease.